As FDA approves marketing for nicotine pouches, some doctors sound alarms
One health advocate called nicotine pouches a "profound risk" for young people.
The U.S. Food and Drug Administration recently approved marketing for four new flavored nicotine pouch products, increasing the total number of such products authorized by the FDA to 30. These pouches, manufactured by subsidiaries of two of the world's largest tobacco companies, Philip Morris International and Altria Group, have raised concerns among health advocates due to their potential appeal to young users.
The FDA's approval comes as part of a series of steps aimed at boosting the fast-growing nicotine pouch sector, with sales of these products surging by 250% between January 2023 and August 2025. While the FDA claims that the modified risk authorization for ZYN, one of the brands covered, does not imply safety, critics warn that the products pose a risk for nicotine addiction among youth.
Written by urgent.news from CBS News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
- FDA authorizes 4 flavored nicotine pouches thehill.com
